Professor Tim Karl
Professor Tim Karl
Western Sydney University, Behavioural Neuroscience
Verified email at - Homepage
Cited by
Cited by
Behavioral phenotyping of mice in pharmacological and toxicological research
T Karl, R Pabst, S von Hörsten
Experimental and Toxicologic Pathology 55 (1), 69-83, 2003
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
G Watt, T Karl
Frontiers in pharmacology 8, 20, 2017
A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
LE Long, R Chesworth, XF Huang, IS McGregor, JC Arnold, T Karl
International Journal of Neuropsychopharmacology 13 (7), 861-876, 2010
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
C Klein, E Karanges, A Spiro, A Wong, J Spencer, T Huynh, ...
Psychopharmacology 218, 443-457, 2011
Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease
WS Kim, H Li, K Ruberu, S Chan, DA Elliott, JK Low, D Cheng, T Karl, ...
Journal of Neuroscience 33 (10), 4387-4394, 2013
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity
D Boey, S Lin, T Karl, P Baldock, N Lee, R Enriquez, M Couzens, K Slack, ...
Diabetologia 49, 1360-1370, 2006
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol
AA Boucher, JC Arnold, L Duffy, PR Schofield, J Micheau, T Karl
Psychopharmacology 192, 325-336, 2007
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice
D Cheng, AS Spiro, AM Jenner, B Garner, T Karl
Journal of Alzheimer's Disease 42 (4), 1383-1396, 2014
Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia
T Karl, L Duffy, A Scimone, RP Harvey, PR Schofield
Genes, Brain and Behavior 6 (7), 677-687, 2007
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
D Cheng, JK Low, W Logge, B Garner, T Karl
Psychopharmacology 231, 3009-3017, 2014
PredictProtein-predicting protein structure and function for 29 years
M Bernhofer, C Dallago, T Karl, V Satagopam, M Heinzinger, M Littmann, ...
Nucleic acids research 49 (W1), W535-W540, 2021
Behavioural profile of a new mouse model for NPY deficiency
T Karl, L Duffy, H Herzog
European Journal of Neuroscience 28 (1), 173-180, 2008
Y1 receptors regulate aggressive behavior by modulating serotonin pathways
T Karl, S Lin, C Schwarzer, A Sainsbury, M Couzens, W Wittmann, D Boey, ...
Proceedings of the National Academy of Sciences 101 (34), 12742-12747, 2004
Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation
M van den Buuse, L Wischhof, RX Lee, S Martin, T Karl
International Journal of Neuropsychopharmacology 12 (10), 1383-1393, 2009
Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety
T Karl, THJ Burne, H Herzog
Behavioural brain research 167 (1), 87-93, 2006
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice
LE Long, R Chesworth, XF Huang, A Wong, A Spiro, IS McGregor, ...
PloS one 7 (4), e34129, 2012
Cognition in transmembrane domain neuregulin 1 mutant mice
L Duffy, E Cappas, D Lai, AA Boucher, T Karl
Neuroscience 170 (3), 800-807, 2010
Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4
N Frerker, L Wagner, R Wolf, U Heiser, T Hoffmann, JU Rahfeld, J Schade, ...
Peptides 28 (2), 257-268, 2007
Behavioral profiling of NPY in aggression and neuropsychiatric diseases
T Karl, H Herzog
Peptides 28 (2), 326-333, 2007
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence
LE Long, R Chesworth, XF Huang, IS McGregor, JC Arnold, T Karl
International Journal of Neuropsychopharmacology 16 (1), 163-175, 2013
The system can't perform the operation now. Try again later.
Articles 1–20